Novocure Ltd
NASDAQ: NVCR0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Frank Leonard
- Employees
- 1,605
- Headquarters
- Baar, Switzerland
- IPO year
- 2015
- Market cap
- $1.7B
- Website
- https://www.novocure.com
Loading NVCR…
Loading profile data…Frequently asked questions about NVCR
What does Novocure Ltd (NVCR) do?
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. Its TTFields devices include Optune Gio, Optune Lua, and Optune Pax. The compa...
Where does NVCR trade?
Novocure Ltd (NVCR) trades on the NASDAQ.
What sector is NVCR in?
Novocure Ltd (NVCR) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Novocure Ltd?
Frank Leonard is the chief executive officer of Novocure Ltd (NVCR).
Where is Novocure Ltd headquartered?
Novocure Ltd is headquartered in Switzerland.
Does NVCR pay a dividend?
Novocure Ltd (NVCR) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did NVCR go public?
Novocure Ltd (NVCR) completed its initial public offering in 2015.